Erick H Turner

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. pmc A taxpayer-funded clinical trials registry and results database
    Erick H Turner
    PLoS Med 1:e60. 2004
  2. doi request reprint Publication bias, with a focus on psychiatry: causes and solutions
    Erick H Turner
    Behavioral Health and Neurosciences Division, Portland Veterans Affairs Medical Center, P3MHDC, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    CNS Drugs 27:457-68. 2013
  3. pmc Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
    PLoS Med 9:e1001189. 2012
  4. doi request reprint Selective publication of antidepressant trials and its influence on apparent efficacy
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    N Engl J Med 358:252-60. 2008
  5. ncbi request reprint Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center
    Steven K Dobscha
    Portland Veterans Affairs Medical Center, Oregon 97207, USA
    Psychiatr Serv 54:195-200. 2003
  6. ncbi request reprint 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin
    Erick H Turner
    Mental Health Division, Mood Disorders Research Center, Portland VA Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    Med Hypotheses 65:138-44. 2005
  7. ncbi request reprint Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
    Erick H Turner
    Mood Disorders Center, Portland VA Medical Center, Portland, OR 97239, USA
    Pharmacol Ther 109:325-38. 2006
  8. doi request reprint Closing a loophole in the FDA Amendments Act
    Erick H Turner
    Science 322:44-6. 2008
  9. pmc Efficacy of antidepressants
    Erick H Turner
    BMJ 336:516-7. 2008
  10. ncbi request reprint Posting FDA new drug application reviews
    Erick H Turner
    JAMA 298:863-4. 2007

Detail Information

Publications11

  1. pmc A taxpayer-funded clinical trials registry and results database
    Erick H Turner
    PLoS Med 1:e60. 2004
  2. doi request reprint Publication bias, with a focus on psychiatry: causes and solutions
    Erick H Turner
    Behavioral Health and Neurosciences Division, Portland Veterans Affairs Medical Center, P3MHDC, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    CNS Drugs 27:457-68. 2013
    ..Protocol publication can further enhance the credibility of the published literature...
  3. pmc Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, Oregon, USA
    PLoS Med 9:e1001189. 2012
    ..Thus one may determine whether publication bias is present and quantify the extent to which it inflates apparent drug efficacy...
  4. doi request reprint Selective publication of antidepressant trials and its influence on apparent efficacy
    Erick H Turner
    Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    N Engl J Med 358:252-60. 2008
    ..Selective publication of clinical trials--and the outcomes within those trials--can lead to unrealistic estimates of drug effectiveness and alter the apparent risk-benefit ratio...
  5. ncbi request reprint Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center
    Steven K Dobscha
    Portland Veterans Affairs Medical Center, Oregon 97207, USA
    Psychiatr Serv 54:195-200. 2003
    ..The authors examined the efficacy of a multifaceted intervention designed to contain the cost of prescribing selective serotonin reuptake inhibitors (SSRIs) to inpatients and outpatients served by a Veterans Affairs (VA) medical center...
  6. ncbi request reprint 5-Hydroxytryptophan plus SSRIs for interferon-induced depression: synergistic mechanisms for normalizing synaptic serotonin
    Erick H Turner
    Mental Health Division, Mood Disorders Research Center, Portland VA Medical Center, 3710 SW US Veterans Hospital Rd, Portland, OR 97239, USA
    Med Hypotheses 65:138-44. 2005
    ..Several double-blind studies have shown 5-HTP to be effective in the treatment of nondrug-induced depression. We hypothesize that patients who become depressed on IFN will respond to the synergistic combination of SSRIs plus 5-HTP...
  7. ncbi request reprint Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan
    Erick H Turner
    Mood Disorders Center, Portland VA Medical Center, Portland, OR 97239, USA
    Pharmacol Ther 109:325-38. 2006
    ..Safety issues with 5-HTP are also reviewed, with emphasis on eosinophilia myalgia syndrome (EMS) and serotonin syndrome...
  8. doi request reprint Closing a loophole in the FDA Amendments Act
    Erick H Turner
    Science 322:44-6. 2008
  9. pmc Efficacy of antidepressants
    Erick H Turner
    BMJ 336:516-7. 2008
  10. ncbi request reprint Posting FDA new drug application reviews
    Erick H Turner
    JAMA 298:863-4. 2007
  11. ncbi request reprint Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder
    Erick H Turner
    Section on Biological Rhythms, Intramural Research Program, National Institute of Mental Health, Bethesda, Maryland, USA
    J Clin Psychopharmacol 22:216-20. 2002
    ..These data suggest that single doses of metergoline may have antidepressant effects that last several days. Possible mechanisms include 5-hydroxytryptamine(2) receptor downregulation and dopamine agonism...